AI analysis of CT scans finds 42.9% of patients have coronary inflammation

Automated excerpt

Biograph, the world’s most advanced preventive health and diagnostics clinic, today announced the completion of its first U. S. study using Caristo Diagnostics’ CaRi-Heart® technology evaluating AI-powered coronary inflammation detection in asymptomatic, low-risk individuals. This collaborative methodology enabled researchers to assess the prevalence of coronary inflammation using the AI-enabled CaRi-Heart technology to determine cardiovascular risk in individuals who may otherwise appear low risk through traditional screening. The study found that coronary inflammation is common (42. 9%) in asymptomatic, low-risk adults and frequently occurs without any plaque buildup or blockage.

Selected automatically from source text; not independently written or fact-checked. Read the original for full context.